Reuters logo
BRIEF-Allergan receives approval for Ozurdex in China for treatment of retinal vein occlusion
2017年10月30日 / 中午12点16分 / 21 天前

BRIEF-Allergan receives approval for Ozurdex in China for treatment of retinal vein occlusion

Oct 30 (Reuters) - Allergan Plc-

* Allergan receives approval for Ozurdex® (dexamethasone intravitreal implant 0.7 mg) in China for the treatment of retinal vein occlusion (RVO)

* Allergan Plc - ‍received imported drugs license from Chinese Food And Drug Administration to market Ozurdex​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below